Among all TRiC subunits, CCT2 has been implicated in modulating the aggregation of various proteins associated with Alzheimer’s disease, tauopathies, and polyglutamine diseases. Here, MARVELD2 is linked to early-onset autosomal dominant Alzheimer disease.